Why Editas Medicine Stock Is Jumping Today
Shares of Editas Medicine (NASDAQ: EDIT) were jumping 9.4% as of 12:27 p.m. EST on Monday. The gain came after the company provided its third-quarter update earlier in the day.
Editas reported revenue in the third quarter of $62.8 million, all of which stemmed from collaboration deals. The average analysts' estimate was for revenue of $4.78 million. The company posted a net loss in Q3 of $39.1 million, or $0.57 per share. This result beat the consensus estimate of a net loss of $0.82 per share.
Image source: Getty Images.
Source Fool.com
